Terms: = Kidney tumors AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Prognosis
10 results:
1. Beyond the genome: malat1's role in advancing urologic cancer care.
Imran M; Abida ; Eltaib L; Siddique MI; Kamal M; Asdaq SMB; Singla N; Al-Hajeili M; Alhakami FA; AlQarni AF; Abdulkhaliq AA; Rabaan AA
Pathol Res Pract; 2024 Apr; 256():155226. PubMed ID: 38452585
[TBL] [Abstract] [Full Text] [Related]
2. Exosomal long non-coding RNA malat1: a candidate of liquid biopsy in monitoring of Wilms' tumor.
Sharma D; Singh A; Wilson C; Swaroop P; Kumar S; Yadav DK; Jain V; Agarwala S; Husain M; Sharawat SK
Pediatr Surg Int; 2024 Feb; 40(1):57. PubMed ID: 38353772
[TBL] [Abstract] [Full Text] [Related]
3. The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma.
Anbiyaee O; Moalemnia A; Ghaedrahmati F; Shooshtari MK; Khoshnam SE; Kempisty B; Halili SA; Farzaneh M; Morenikeji OB
BMC Nephrol; 2023 Dec; 24(1):380. PubMed ID: 38124072
[TBL] [Abstract] [Full Text] [Related]
4. Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment.
Jiang Y; Wang Y; Wang Z; Zhang Y; Hou Y; Wang X
Sci Rep; 2023 Nov; 13(1):18909. PubMed ID: 37919386
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis.
Zhou L; Ye J; Wen F; Yu H
Dis Markers; 2022; 2022():4033583. PubMed ID: 35320950
[TBL] [Abstract] [Full Text] [Related]
6. Noncoding RNAs orchestrate cell growth, death and drug resistance in renal cell carcinoma.
Fawzy MS; Toraih EA; Ageeli EA; Al-Qahtanie SA; Hussein MH; Kandil E
Epigenomics; 2020 Feb; 12(3):199-219. PubMed ID: 32011160
[No Abstract] [Full Text] [Related]
7. LncRNA malat1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
Ye Y; Zhang F; Chen Q; Huang Z; Li M
Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
[TBL] [Abstract] [Full Text] [Related]
8. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis.
Chen J; Chen Y; Gu L; Li X; Gao Y; Lyu X; Chen L; Luo G; Wang L; Xie Y; Duan J; Peng C; Ma X
Oncotarget; 2016 Nov; 7(45):74325-74336. PubMed ID: 27527868
[TBL] [Abstract] [Full Text] [Related]
9. [Renal cell carcinoma with t(6;11)(p21.2;q13)/malat1-TFEB fusion: a clinical and pathological analysis].
Xia Q; Shi S; Shen Q; Wei X; Wang X; Ma H; Lu Z; Zhou X; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):895-9. PubMed ID: 26888508
[TBL] [Abstract] [Full Text] [Related]
10. Upregulation of long non-coding RNA malat1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract] [Full Text] [Related]
